TY  - JOUR

T1  - Cost effectiveness of ranibizumab vs aflibercept vs bevacizumab for the treatment of macular oedema due to central retinal vein occlusion: the LEAVO study

JO  - PharmacoEconomics

UR  - https://eprints.whiterose.ac.uk/id/eprint/173442

PY  - 2021/08/01

AU  - Pennington R

AU  - Alshreef A

AU  - Flight L

AU  - Metry A

AU  - Poku E

AU  - Hykin P

AU  - Sivaprasad S

AU  - Prevost AT

AU  - Vasconcelos JC

AU  - Murphy C

AU  - Kelly J et al

ED  - 

DO  - DOI: 10.1007/s40273-021-01026-5

PB  - Springer

VL  - 39

IS  - 8

SP  - 913

EP  - 927

Y2  - 2025/11/20

ER  -